ten Kate FJ - Search Results

1

Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients.

Brouwer JT, Nevens F, Kleter B, Elewaut A, Adler M, Brenard R, Chamuleau RA, Michielsen PP, Pirotte J, Hautekeete ML, Weber J, Bourgeois N, Hansen BE, Bronkhorst CM, ten Kate FJ, Heijtink RA, Fevery J, Schalm SW. Brouwer JT, et al. Among authors: ten kate fj. J Hepatol. 1998 Jun;28(6):951-9. doi: 10.1016/s0168-8278(98)80342-5. J Hepatol. 1998. PMID: 9672169 Clinical Trial.

2

Phenprocoumon-induced hepatitis mimicking non-A, non-B hepatitis.

de Man RA, Wilson JH, Schalm SW, ten Kate FJ, van Leer E. de Man RA, et al. Among authors: ten kate fj. J Hepatol. 1990 Nov;11(3):318-21. doi: 10.1016/0168-8278(90)90214-c. J Hepatol. 1990. PMID: 1963177

3

beta 2-Microglobulin and antiviral therapy for chronic hepatitis type B.

de Man RA, Lindemans J, Schalm SW, ten Kate FJ. de Man RA, et al. Among authors: ten kate fj. Antiviral Res. 1989 May-Jun;11(4):181-90. doi: 10.1016/0166-3542(89)90003-x. Antiviral Res. 1989. PMID: 2662897 Clinical Trial.

4

Long-term follow-up of antiviral combination therapy in chronic hepatitis B.

De Man RA, Schalm SW, Heijtink RA, Berk L, Den Ouden J, ten Kate FJ, Chamuleau RA, Reesink HW. De Man RA, et al. Among authors: ten kate fj. Am J Med. 1988 Aug 29;85(2A):150-4. Am J Med. 1988. PMID: 3044080 Clinical Trial.

5

Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: results of a randomized, placebo-controlled trial.

Janssen HL, Berk L, Heijtink RA, ten Kate FJ, Schalm SW. Janssen HL, et al. Among authors: ten kate fj. Hepatology. 1993 Mar;17(3):383-8. Hepatology. 1993. PMID: 8444411 Clinical Trial.

6

Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP).

Janssen HL, Gerken G, Carreño V, Marcellin P, Naoumov NV, Craxi A, Ring-Larsen H, Kitis G, van Hattum J, de Vries RA, Michielsen PP, ten Kate FJ, Hop WC, Heijtink RA, Honkoop P, Schalm SW. Janssen HL, et al. Among authors: ten kate fj. Hepatology. 1999 Jul;30(1):238-43. doi: 10.1002/hep.510300113. Hepatology. 1999. PMID: 10385662 Clinical Trial.

7

Prognostic factors and long-term effects of ursodeoxycholic acid on liver biochemical parameters in patients with primary biliary cirrhosis. Dutch Multi-Centre PBC Study Group.

van Hoogstraten HJ, Hansen BE, van Buuren HR, ten Kate FJ, van Berge-Henegouwen GP, Schalm SW. van Hoogstraten HJ, et al. Among authors: ten kate fj. J Hepatol. 1999 Aug;31(2):256-62. doi: 10.1016/s0168-8278(99)80222-0. J Hepatol. 1999. PMID: 10453938

8

Course of hepatitis B and D virus infection in auxiliary liver grafts in hepatitis B-positive patients. A light-microscopic and immunohistochemical study.

ten Kate FJ, Schalm SW, Willemse PJ, Blok AP, Heijtink RA, Terpstra OT. ten Kate FJ, et al. J Hepatol. 1992 Mar;14(2-3):168-75. doi: 10.1016/0168-8278(92)90154-h. J Hepatol. 1992. PMID: 1500681

9

Course of hepatitis delta virus infection in auxiliary liver grafts in patients with delta virus cirrhosis.

ten Kate FJ, Schalm SW. ten Kate FJ, et al. Prog Clin Biol Res. 1991;364:429-37. Prog Clin Biol Res. 1991. PMID: 2020719

10

Detection of HBV-DNA in liver biopsy and serum: its significance in the selection of hepatitis B patients for antiviral therapy.

Heijtink RA, Smal P, ten Kate FJ, Kruining J, Schalm SW. Heijtink RA, et al. Among authors: ten kate fj. Antiviral Res. 1987 Jul;7(6):329-40. doi: 10.1016/0166-3542(87)90015-5. Antiviral Res. 1987. PMID: 3674854

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

402 results

Search Page